Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

Xiaoxuan Liu(University Hospitals Birmingham NHS Foundation Trust), Samuel Rowley(MRC Clinical Trials Unit at UCL), Cyrus Espinoza(Birmingham Community Healthcare NHS Trust), Jonathan J Deeks(Birmingham City University), Hugh Harvey(United States Food and Drug Administration), M. Khair ElZarrad(Center for Drug Evaluation and Research), Lavinia Ferrante di Ruffano(University of Applied Health Sciences), Adrian Jonas(University of Toronto), Christopher Kelly(Google (United States)), Aaron Lee(Imperial College London), Cynthia D. Mulrow(The University of Texas at San Antonio Health Science Center), John Fletcher(University of Birmingham), Samantha Cruz Rivera(University of Birmingham), Robert Golub(American Medical Association), Livia Faes(Moorfields Eye Hospital NHS Foundation Trust), Hutan Ashrafian(NIHR Imperial Biomedical Research Centre), Ara Darzi(Imperial College Healthcare NHS Trust), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Dina N. Paltoo(National Institutes of Health), Melissa D. McCradden(3M (United States)), Charlotte Haug, Cecilia S. Lee(University of Washington), David Moher(University of Ottawa), Andre Esteva(Artistic Realization Technologies), Maria Beatrice Panico(University of Rome Tor Vergata), Melanie Calvert(NIHR Birmingham Biomedical Research Centre), Alastair K. Denniston(UK Biobank), Andrew L. Beam(Harvard University), Elaine Manna(The Patients Association), Richard S. Savage(Bridgepoint (United Kingdom)), João Monteiro(The Nature Conservancy), Rupa Sarkar, Christopher Holmes(University of Oxford), James Matcham(Goethe University Frankfurt), Gary Price(AstraZeneca (United Kingdom)), Sebastian J. Vollmer(National Institute for Health and Care Excellence), Luke Oakden‐Rayner(Royal Adelaide Hospital), Pearse A. Keane(University College London)
Nature Medicine
September 1, 2020
Cited by 1,168


Related Papers